| |  Online-Ressource |
|---|
| Verfasst von: | Israel, Carsten W. [VerfasserIn]  |
|---|
| | Staudacher, Ingo [VerfasserIn] |
|---|
| | Leclercq, Christophe [VerfasserIn] |
|---|
| | Botto, Giovanni Luca [VerfasserIn] |
|---|
| | Scherr, Daniel [VerfasserIn] |
|---|
| | Fach, Andreas [VerfasserIn] |
|---|
| | Duru, Firat [VerfasserIn] |
|---|
| | Zylla, Maura Magdalena [VerfasserIn] |
|---|
| | Katus, Hugo [VerfasserIn] |
|---|
| | Thomas, Dierk [VerfasserIn] |
|---|
| Titel: | Sudden cardiac death while waiting |
|---|
| Titelzusatz: | do we need the wearable cardioverter-defibrillator? |
|---|
| Verf.angabe: | Carsten Israel, Ingo Staudacher, Christophe Leclercq, Giovanni Luca Botto, Daniel Scherr, Andreas Fach, Firat Duru, Maura M. Zylla, Hugo A. Katus, Dierk Thomas |
|---|
| E-Jahr: | 2022 |
|---|
| Jahr: | 19 March 2022 |
|---|
| Umfang: | 9 S. |
|---|
| Fussnoten: | Gesehen am 25.09.2024 |
|---|
| Titel Quelle: | Enthalten in: Clinical research in cardiology |
|---|
| Ort Quelle: | Berlin : Springer, 2006 |
|---|
| Jahr Quelle: | 2022 |
|---|
| Band/Heft Quelle: | 111(2022), 11, Seite 1189-1197 |
|---|
| ISSN Quelle: | 1861-0692 |
|---|
| Abstract: | Sudden cardiac death (SCD) is the most frequent cause of cardiovascular death in industrialized nations. Patients with cardiomyopathy are at increased risk for SCD and may benefit from an implantable cardioverter-defibrillator (ICD). The risk of SCD is highest in the first months after myocardial infarction or first diagnosis of severe non-ischemic cardiomyopathy. On the other hand, left ventricular function may improve in a subset of patients to such an extent that an ICD might no longer be needed. To offer protection from a transient risk of SCD, the wearable cardioverter-defibrillator (WCD) is available. Results of the first randomized clinical trial investigating the role of the WCD after myocardial infarction were recently published. This review is intended to provide insight into data from the VEST trial, and to put these into perspective with studies and clinical experience. As a non-invasive, temporary therapy, the WCD may offer advantages over early ICD implantation. However, recent data demonstrate that patient compliance and education play a crucial role in this new concept of preventing SCD. |
|---|
| DOI: | doi:10.1007/s00392-022-02003-4 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
kostenfrei: Volltext: https://doi.org/10.1007/s00392-022-02003-4 |
|---|
| | kostenfrei: Volltext: https://link.springer.com/article/10.1007/s00392-022-02003-4 |
|---|
| | DOI: https://doi.org/10.1007/s00392-022-02003-4 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Implantable cardioverter-defibrillator |
|---|
| | Myocardial infarction |
|---|
| | Sudden cardiac death |
|---|
| | Ventricular tachycardia |
|---|
| | Wearable cardioverter-defibrillator |
|---|
| K10plus-PPN: | 1903446007 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Sudden cardiac death while waiting / Israel, Carsten W. [VerfasserIn]; 19 March 2022 (Online-Ressource)
